Search Results - "Jericó, C"

Management of peri-surgical anemia in elective surgery. Conclusions and recommendations according to Delphi-UCLA methodology by Moral, V., Abad Motos, A., Jericó, C., Antelo Caamaño, M.L., Ripollés Melchor, J., Bisbe Vives, E., García Erce, J.A.

“…Preoperative anemia affects approximately one third of surgical patients. It increases the risk of blood transfusion and influences short- and medium-term…”
Get full text

Patient Blood Management for primary hip and knee replacement. A survey among POWER.2 study researchers by Abad-Motos, A, Ripollés-Melchor, J, Jericó, C, Basora, M, Aldecoa, C, Cabellos-Olivares, M, Navarro-Pérez, R, Bisbe, E, García-Erce, J A

“…Implementation of Patient Blood Management programs remain variable in Europe, and even in centres with well-established PBM programs variability exists in…”
Get full text

Postoperative Outcomes Within an Enhanced Recovery after surgery protocol in gastric surgery for cancer (POWER.4): Study protocol for a prospective, multicentre, observational cohort study by Abad-Motos, A, Ripollés-Melchor, J, Bruna-Esteban, M, Ferrando-Ortolá, C, Paseiro-Crespo, G, Abad-Gurumeta, A, García-Erce, J A, Jericó, C, Ramírez, J M, Aldecoa, C

“…Enhanced recovery pathways or ERAS have been applied in gastric cancer surgery extrapolated from colorectal surgery. The objective of the study is to assess…”
Get full text

PBM: Now more than ever necessary by García-Erce, J A, Jericó, C, Abad-Motos, A, Rodríguez García, J, Antelo Caamaño, M L, Domingo Morera, J M, Sola Lapeña, C, Arroyo, J L, Fernández Fuertes, F, Zalba Marcos, S, Cerdán Rodríguez, G, Laso Morales, M J, Bueno Cabrera, J L, Chica, E, Recasens, V, Zabalegui, A, Balen, E, Urrechaga, E, Abad-Gurumeta, A, Quintana Díaz, M

Get full text

Improving collaboration between ecosystem service communities and the IPBES science-policy platform by Washbourne, C.-L., Dendoncker, N., Jacobs, S., Mascarenhas, A., De Longueville, F., van Oudenhoven, A. P. E., Schröter, M., Willemen, L., Campagne, S., Jones, S.K., Garcia-Llorente, M., Iniesta-Arandia, I., Baró, F., Fisher, J., Förster, J., Jericó-Daminelo, C., Lecina-Diaz, J., Lavorel, S., Lliso, B., Montealgre Talero, C., Morán-Ordóñez, A., Roces-Díaz, J.V., Schlaepfer, M.A., Van Dijk, J.

“…The end of the first working program of the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) provided an opportunity to…”
Get full text

PBM: Now more than ever necessary by García-Erce, J A, Jericó, C, Abad-Motos, A, Rodríguez García, J, Antelo Caamaño, M L, Domingo Morera, J M, Sola Lapeña, C, Arroyo, J L, Fernández Fuertes, F, Zalba Marcos, S, Cerdán Rodríguez, G, Laso Morales, M J, Bueno Cabrera, J L, Chica, E, Recasens, V, Zabalegui, A, Balen, E, Urrechaga, E, Abad-Gurrumenta, A, Quintana Díaz, M

Get full text

Exploring perceptions of stakeholder roles in ecosystem services coproduction by Jericó-Daminello, C., Schröter, B., Mancilla Garcia, M., Albert, C.

“…•We investigate stakeholder groups’ self-perceived and attributed roles with social network analysis.•The Lahn River case study reveals substantial differences…”
Get full text

Área de Atención Integrada de Riesgo Vascular: un nuevo modelo organizativo para el control global de los factores de riesgo by Armario, P, Jericó, C, Vila, L, Freixa, R, Martin-Castillejos, C, Rotllan, M

“…Resumen La enfermedad cardiovascular (ECV) es una causa importante de morbimortalidad que incrementa el coste asistencial. Actualmente existe un bajo grado de…”
Get full text

ICTERÍCIA LIKE RELACIONADA AO USO DE ELTROMBOPAG EM PACIENTE SUBMETIDA A TRANSPLANTE DE CÉLULAS TRONCO HEMATOPOÉTICAS by PC Jericó, TDM Monteiro, AL Emrich

“…Introdução: Apesar dos constantes avanços relacionados ao TCTH (Transplante de Células-Tronco Hematopoiéticas), a falha de enxertia ainda ocorre em cerca de 5%…”
Get full text

Executive summary of the consensus document on the management of perioperative anemia in Spain by Muñoz, M., Aragón, S., Ballesteros, M., Bisbe-Vives, E., Jericó, C., Llamas-Sillero, P., Meijide-Míguez, H.M., Rayó-Martin, E., Rodríguez-Suárez, M.J.

“…Perioperative anemia is an independent risk factor for postoperative morbidity and mortality. However, conceptual, logistical and administrative barriers…”
Get full text

LEUCEMIA LINFOBLÁSTICA AGUDA T RECIDIVADA EM GLÂNDULA LACRIMAL APÓS TRANSPLANTE DE CÉLULAS-TRONCO HEMATOPOIÉTICAS ALOGÊNICO by AL Emrich, TDM Monteiro, LE Toyonaga, PC Jericó

“…Introdução: A leucemia linfoblástica aguda de células T (LLA-T) é uma neoplasia hematológica de difícil tratamento. Este relato descreve um caso de LLA-T…”
Get full text

Reply to «Transfusions in the emergency department: Are there other care alternatives? by Quintana-Díaz, M, Jericó-Alba, C, Zalba-Marcos, S, García-Erce, J A

Get full text

Sildenafil and coronary artery disease by Iglesias, M.L., Jericó, C., Skaf, E., Pedro‐Botet, J.

Get full text

Evaluation and treatment of anemia prior to surgery: A challenge to improve by Jericó Alba, C, Ripollés-Melchor, J, Ramírez-Rodríguez, J M, García-Erce, J A

Get full text

SARCOMA GRANULOCÍTICO COMO SINTOMA DE APRESENTAÇÃO DA LEUCEMIA MIELOIDE CRÔNICA EM FASE BLÁSTICA: RELATO DE CASO by BMB Bregagnollo, AB Scheffer, P Eickhoff, PJM João, VJF Corrêa, MTC Rodrigues, PC Jericó, AL Emrich, TS Arruda, MB Carvalho

“…Introdução: O sarcoma granulocítico (SG) é uma neoplasia rara constituída por células mieloides imaturas que formam uma massa tumoral extramedular e ocorre em…”
Get full text

Evaluation and Treatment of Anemia Prior to Surgery: A Challenge to Improve by Jericó Alba, C., Ripollés-Melchor, J., Ramírez-Rodríguez, J.M., García-Erce, J.A.

Get full text

Impact on clinical practice of the preoperative screening of Covid-19 infection in surgical oncological patients. Prospective cohort study by Castellvi, J., Jerico, C., DeMiguel, A., Camacho, D., Mullerat, J.M., Catala, J., Cliville, R., Videla, S.

“…In the oncological patient, an COVID-19-Infection, whether symptomatic or asymptomatic, a surgical procedure may carry a higher postoperative morbidity and…”
Get full text

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study by Stroes, Erik, Guyton, John R., Lepor, Norman, Civeira, Fernando, Gaudet, Daniel, Watts, Gerald F., Baccara‐Dinet, Marie T., Lecorps, Guillaume, Manvelian, Garen, Farnier, Michel, Kostner, K., Lehman, S., Descamps, O., Gheyle, L., Mathieu, C., Bergeron, J., Elliott, T., Girard, G., Gupta, A., Hoag, G., Hove, J., Jeppesen, J., Kjærulf, J.H., Klarlund, K., Thomsen, K.K., Basart, D.C.G., Kooy, A., Liem, A., Swart, H., Troquay, R., Van Het Hof‐Wiersma, J, Viergever, P., Visseren, F., Doughty, R.N., Scott, R., Calvo, C., Díaz‐Díaz, J.L., Fuentes, F., Gil‐Extremera, B., Jericó, C., Matas Pericas, L., Mediavilla Garcia, J.D., Bolster, D.E., Koren, M., El Shahawy, M., Vardi, G., Weinstein, D., Zuzarte, K., Ginsberg, Henry, Robinson, Jennifer G., Rader, Daniel J., Cannon, Christopher P., Colhoun, Helen, Kastelein, John J.P., Huo, Yong, Olsson, Anders, Waters, David, Larrey, Dominique, Rosenson, Robert S., Patriarca, Peter A., Molenberghs, Geert, Tricoci, Pierluigi, Mahaffey, Kenneth W., Lopes, Renato D., Shah, Bimal R., Mehta, Rajendra H., Roe, Matthew T., Eapen, Zubin, Armaganijan, Luciana, Bertolami, Adriana, Leonardi, Sergio, Kolls, Bradley J., Jordan, J. Dedrick, Ducrocq, Grégory, Puymirat, Etienne, Mathews, Robin

“…Background The PCSK9 antibody alirocumab (75 mg every 2 weeks; Q2W) as monotherapy reduced low‐density lipoprotein‐cholesterol (LDL‐C) levels by 47%. Because…”
Get full text

Perceptions and Likelihood of Medical Students to Pursue a Career in Neurosurgery: Findings from the Philippines by Chan, Kevin Ivan P., Khu, Kathleen Joy O., Brillante, Edroico Mari B., Flores, Gabrielle P., Nakpil, Aurora S., Go, Dan Alexander D., Dantes, Justine Karl C., Manlapid, Jerico Mari C., Legaspi, Gerardo D.

“…The number of neurosurgeons in the Philippines is less than ideal for its population, so there is a need to recruit and train more. This study aimed to…”
Get full text

Patient Blood Management for primary hip and knee replacement. A survey among POWER.2 study researchers by Abad-Motos, A., Ripollés-Melchor, J., Jericó, C., Basora, M., Aldecoa, C., Cabellos-Olivares, M., Navarro-Pérez, R., Bisbe, E., García-Erce, J.A.

“…Implementation of Patient Blood Management programmes remain variable in Europe, and even in centres with well-established PBM programmes variability exists in…”
Get full text